These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17225301)

  • 1. How to prevent 500,000 heart attacks a year. Widespread screening for CVD could pinpoint who's vulnerable.
    Duke Med Health News; 2006 Nov; 12(11):1, 11. PubMed ID: 17225301
    [No Abstract]   [Full Text] [Related]  

  • 2. Using nontraditional risk factors in coronary heart disease risk assessment.
    Lin KW; Garcia SM
    Am Fam Physician; 2011 Feb; 83(4):449. PubMed ID: 21322521
    [No Abstract]   [Full Text] [Related]  

  • 3. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK;
    Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting your odds of having a heart attack. The best screening tool for people at intermediate risk.
    Johns Hopkins Med Lett Health After 50; 2012 Dec; 24(11):1-2. PubMed ID: 23342668
    [No Abstract]   [Full Text] [Related]  

  • 5. Should high sensitive C-reactive protein measurement be included in health screening packages?
    Hawkins RC; Leong L
    Singapore Med J; 2006 Oct; 47(10):837-40. PubMed ID: 16990957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for coronary heart disease: recommendation statement.
    Am Fam Physician; 2004 Jun; 69(12):2891-4. PubMed ID: 15222654
    [No Abstract]   [Full Text] [Related]  

  • 7. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
    Naghavi M; Libby P; Falk E; Casscells SW; Litovsky S; Rumberger J; Badimon JJ; Stefanadis C; Moreno P; Pasterkamp G; Fayad Z; Stone PH; Waxman S; Raggi P; Madjid M; Zarrabi A; Burke A; Yuan C; Fitzgerald PJ; Siscovick DS; de Korte CL; Aikawa M; Airaksinen KE; Assmann G; Becker CR; Chesebro JH; Farb A; Galis ZS; Jackson C; Jang IK; Koenig W; Lodder RA; March K; Demirovic J; Navab M; Priori SG; Rekhter MD; Bahr R; Grundy SM; Mehran R; Colombo A; Boerwinkle E; Ballantyne C; Insull W; Schwartz RS; Vogel R; Serruys PW; Hansson GK; Faxon DP; Kaul S; Drexler H; Greenland P; Muller JE; Virmani R; Ridker PM; Zipes DP; Shah PK; Willerson JT
    Circulation; 2003 Oct; 108(15):1772-8. PubMed ID: 14557340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular prevention: new study, new guidelines. The effort keeping the heart healthy].
    Einecke D
    MMW Fortschr Med; 2004 Sep; 146(38):4-6, 8. PubMed ID: 15532422
    [No Abstract]   [Full Text] [Related]  

  • 9. The things to come of SHAPE: cost and effectiveness of cardiovascular prevention.
    Diamond GA; Kaul S
    Am J Cardiol; 2007 Apr; 99(7):1013-5. PubMed ID: 17398203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Depressive and sleepless: caution of myocardial infarct risk. Secondary risk factors].
    Aumiller J
    MMW Fortschr Med; 2009 May; 151(20):18-9. PubMed ID: 19728656
    [No Abstract]   [Full Text] [Related]  

  • 11. Physician-focused disease management program contributes to reductions in heart attacks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Jan; 13(2):1-2, 5. PubMed ID: 12425317
    [No Abstract]   [Full Text] [Related]  

  • 12. American Heart Association consensus panel statement on preventing heart attack and death in patients with coronary disease.
    Kennedy JW
    J Am Coll Cardiol; 1995 Jul; 26(1):291. PubMed ID: 7797766
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiation and coronary calcium screening.
    Stein JH
    Am J Cardiol; 2007 Nov; 100(9):1495. PubMed ID: 17950819
    [No Abstract]   [Full Text] [Related]  

  • 14. New diagnostic test may help prevent deadly heart attacks in patients with acute coronary syndrome.
    Manos D
    Rep Med Guidel Outcomes Res; 2003 Dec; 14(24):1-2, 6-7. PubMed ID: 14677562
    [No Abstract]   [Full Text] [Related]  

  • 15. [Guidelines: Acute coronary syndrome (ACS). II: Acute coronary syndrome with ST-elevation].
    Hamm CW
    Z Kardiol; 2004 Apr; 93(4):324-41. PubMed ID: 15085379
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening guidelines for coronary heart disease in diabetes: current recommendations.
    Singh S; Duggal J; Khosla N; Arora R
    J Cardiometab Syndr; 2009; 4(2):107-12. PubMed ID: 19614798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac risk stratification for postmyocardial infarction dental patients.
    Roberts HW; Mitnitsky EF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):676-81. PubMed ID: 11402281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health screening packages: the place of measuring C-reactive protein.
    Wong MS
    Singapore Med J; 2006 Oct; 47(10):827-9. PubMed ID: 16990955
    [No Abstract]   [Full Text] [Related]  

  • 19. An assessment of the new lipid screening guidelines.
    Steiner MJ; Brown WD; Liles E
    Pediatrics; 2008 Oct; 122(4):904-5; author reply 906-7. PubMed ID: 18829821
    [No Abstract]   [Full Text] [Related]  

  • 20. Two approaches of coronary risk assessment--do they work?
    Ajani UA; Ford ES
    Am J Cardiol; 2006 Mar; 97(6):765-7. PubMed ID: 16516571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.